Medicinal Product Shortages - update - 31 January 2024

Notice type: Advisory

Date: 31/01/2024

This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.

Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

 

Resolved shortages

The following shortages have been resolved and supply has resumed to the Irish market:

Product

Active Ingredient(s)

Amlode 5mg Tablets

PA0711/138/001

Rowex Ltd

Amlodipine

Betnovate Cream 0.1% w/w

PA1077/001/001

GlaxoSmithKline (Ireland) Limited

Betamethasone

Cellcept 500mg Powder for concentrate for Solution for Infusion

EU/1/96/005/005

Roche Registration GmbH

Mycophenolate

Deslor 5mg Film Coated Tablets

PA0711/202/001

Rowex Ltd

Desloratidine

Entyvio 108/0.68mg Solution for injection in pre-filled pen

EU/1/14/923/005

Takeda Pharma A/S

Vedolizumab

Equasym XL 30mg Modified Release Capsules, Hard

PA23211/001/003

Takeda Pharmaceuticals International AG Ireland Branch

Methylphenidate

Gabin 400mg Capsules

PA1445/020/003

Aurobindo Pharma (Malta) Limited

Gabapentin

Ibuprofen B. Braun 400mg Solution for Infusion

PA0736/041/001

B. Braun Melsungen AG

Ibuprofen

Keflex 500 mg Film-Coated Tablets

PA1226/002/004

Flynn Pharma Limited

Cefalexin

Mycolat 500mg Film Coated Tablets

PA0711/129/002

Rowex Ltd

Mycophenolate

Nebivolol Teva 5mg Tablets

PA0749/078/001

Teva Pharma B.V

Nebivolol

Ondansetron 2mg/ml Solution for Injection

(2ml ampoule)

PA1122/004/001

Noridem Enterprises Limited

Ondansetron

Ramipril Teva Pharma 2.5mg Tablets

PA0749/177/002

Teva Pharma B.V

Ramipril

Tevaquel XL 400 mg Prolongedrelease tablets

PA0749/060/009

Teva Pharma B.V

Quetiapine

Valcyte 450 mg film-coated tablets

PA2239/023/001

CHEPLAPHARM Arzneimittel GmbH

Valganciclovir

Vertigon 8mg Tablets

PA1445/023/001

Aurobindo Pharma (Malta) Limited

Betahistine

Vertigon 16mg Tablets

PA1445/023/002

Aurobindo Pharma (Malta) Limited

Betahistine

Xyrem 500 mg/mL oral solution

EU/1/05/312/001

UCB Pharma SA

Sodium oxybate

 

Newly notified shortages

The HPRA has been notified of a shortage of the following products:

Product

Active Ingredient(s)

Cellcept 250mg Hard Capsules

EU/1/96/005/001

Roche Registration GmbH

Mycophenolate

Deslor 0.5 mg/ml Oral Solution

PA0711/202/002

Rowex Ltd

Desloratidine

ENAP 10mg Tablets

PA0711/028/002

Rowex Ltd

 

Enalapril

Eplerenone Krka 25 mg film-coated tablets

PA1347/078/001

KRKA, d.d., Novo mesto

Eplerenone

Isotretinoin 10mg Soft Capsules

PA0711/312/002

Rowex Ltd

Isotretinoin

Mirap 30mg Film Coated Tablets

PA0711/062/002

Rowex Ltd

Mirtazapine

Mirap DisTab 30mg Orodispersible Tablets

PA0711/094/002

Rowex Ltd

Mirtazapine

Mirap DisTab 45mg Orodispersible Tablets

PA0711/094/003

Rowex Ltd

Mirtazapine

Nebol 5 mg Tablets

PA0711/120/001

Rowex Ltd

Nebivolol

Telmisartan Rowa 20 mg tablets

PA0074/078/001

Rowa Pharmaceuticals Limited

Telmisartan

Telmisartan Rowa 40 mg tablets

PA0074/078/002

Rowa Pharmaceuticals Limited

Telmisartan

Telmisartan Rowa 80 mg tablets

PA0074/078/003

Rowa Pharmaceuticals Limited

Telmisartan

Zimoclone 7.5mg Film Coated Tablets

PA23266/009/001

Vitatris Limited

Zopiclone

Zonegran 100mg Capsule

EU/1/04/307/004

Amdipharm Limited

Zonisamide

Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.



« Back